CAS 164579-32-2

Pantoprazole sodium sesquihydrate

Description:

Pantoprazole sodium sesquihydrate is a proton pump inhibitor primarily used to treat gastroesophageal reflux disease (GERD) and other conditions associated with excessive stomach acid production. It is a white to off-white crystalline powder that is soluble in water and exhibits a pH-dependent solubility profile, which enhances its absorption in the gastrointestinal tract. The chemical formula reflects its sodium salt form, indicating the presence of sodium ions, and the sesquihydrate designation indicates that it contains one and a half molecules of water for each molecule of pantoprazole. Pantoprazole acts by irreversibly inhibiting the H+/K+ ATPase enzyme in the gastric parietal cells, leading to a decrease in gastric acid secretion. Its pharmacokinetics show a rapid onset of action, with peak plasma concentrations typically occurring within a few hours after administration. The substance is generally well-tolerated, though it may have side effects such as headache, gastrointestinal disturbances, and, in rare cases, more serious effects like kidney issues or vitamin B12 deficiency with long-term use.

Formula: C₁₆H₁₅F₂N₃O₄SH₂O·Na

InChI: InChI=1S/C16H15F2N3O4S.Na.H2O/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16;;/h3-7,15H,8H2,1-2H3,(H,20,21);;1H2

InChI key: InChIKey=RJRBTVMZZGMTQI-UHFFFAOYSA-N

SMILES: S(CC1=C(OC)C(OC)=CC=N1)(=O)C=2NC=3C(N2)=CC(OC(F)F)=CC3.[Na].O

Synonyms:

• 1H-Benzimidazole, 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-, sodium salt, hydrate (2:3)
• 1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt, hydrate (2:2:3)
• 1H-benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1)
• 5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridyl)methyl)sulfinyl)benzimidazole, sodium salt, sesquihydrate
• Allpan
• Pantocip
• Pantodac
• Pantop
• Pantoprazole sodium hydrate
• Pantoprazole sodium sesquihydrate
• Pantosec

PANTOPRAZOLE SODIUM SESQUIHYDRATE CRS

CAS: 164579-32-2

PANTOPRAZOLE SODIUM SESQUIHYDRATE CRS

Formula: C₁₆H₁₈F₂N₃NaO₅S

Color and Shape: White. Powder.

Molecular weight: 425.3828

Ref: 41-Y0000835

PANTOPRAZOLE FOR SYSTEM SUITABILITY CRS

CAS: 164579-32-2

PANTOPRAZOLE FOR SYSTEM SUITABILITY CRS

Ref: 41-Y0001001

Pantoprazole Sodium

CAS: 164579-32-2

Compounds containing an unfused pyridine ring in the structure, nesoi

Formula: C₁₆H₁₄F₂N₃NaO₄S·5H₂O

Color and Shape: White Off-White Crystalline Powder

Molecular weight: 405.05708

Ref: 45-1494895

1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt, hydrate (2:2:3)

CAS: 164579-32-2

Formula: C₁₆H₂₀F₂N₃NaO₇S

Purity: 99%

Color and Shape: Solid

Molecular weight: 459.3975

Ref: IN-DA001UYC

Pantoprazole Sodium Hydrate

CAS: 164579-32-2

Pantoprazole Sodium Hydrate

Purity: ≥95%

Molecular weight: 432.37g/mol

Ref: 54-BUP17374

Pantoprazole Sodium Hydrate

CAS: 164579-32-2

Pantoprazole Sodium Hydrate (BY1023 (sodium hydrate)) is a proton pump inhibitor drug, used for short-term treatment of erosion and ulceration of the esophagus

Formula: C₁₆H₁₄F₂N₃NaO₄SH₂O

Purity: 98.32%

Color and Shape: Solid

Molecular weight: 432.37

Ref: TM-T0161

Pantoprazole Sodium Sesquihydrate

CAS: 164579-32-2

Formula: C₁₆H₁₄F₂N₃NaO₄SH₂O

Purity: >98.0%(T)(HPLC)

Color and Shape: White to Light yellow powder to crystal

Molecular weight: 432.37

Ref: 3B-P3231

Pantoprazole Sodium Hydrate

CAS: 164579-32-2

Formula: C₁₆H₁₄F₂N₃O₄SNaH₂O

Color and Shape: Neat

Molecular weight: 864.75

Ref: TR-P183350

Pantoprazole Sodium Sesquihydrate

CAS: 164579-32-2

Formula: C₁₆H₁₄F₂N₃O₄SNa(H₂O)

Molecular weight: 382.4 : 23.0 : 3/2(18.0)

Ref: ST-EA-CP-P15017